What is Phathom Pharmaceuticals, Inc.'s financing cash flow?

Phathom Pharmaceuticals, Inc. (PHAT) reported financing cash flow of $66.64M in Q1 2026.

What is the long-term trend for Phathom Pharmaceuticals, Inc.'s financing cash flow?

Over 3 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s financing cash flow has grown at a -81.4% compound annual growth rate (CAGR), from $44.71M to -$288K.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Phathom Pharmaceuticals, Inc. PHAT Financing Cash Flow

Financing Cash Flow at other companies

Opko HealthOPK

-$5.16M-28.2%

Zevra Therapeutics, Inc.ZVRA

-$52.8M-3,386%

AMP

Amphastar PharmaceuticalsAMPH

-$30.21M-108%

Theravance BiopharmaTBPH

-$5.58M-553%

HRO

HarrowHROW

$48.91M+212,561%

PrecigenPGEN

$109K+116%

Other financials

Income statement

See full

Revenue$58.3M+104%

Gross profit$46.3M+86.8%

Operating income-$15.5M+80.4%

Net income-$30.4M+67.8%

EPS (diluted)-$0.37+71.8%

Balance sheet

See full

Cash & equivalents$180.9M-14.8%

Total debt$166.3M-18.3%

Total equity-$337.0M+0.4%

Total assets$305.1M+3.7%

Cash flow

See full

Operating cash flow-$15.6M+81.6%

CapEx$61.0K+239%

Free cash flow-$15.7M+81.5%

Valuation

See full

Market cap$846.21M+13.4%

Enterprise value$831.61M+12.7%

P/S4.1×-5.0×

Profitability

See full

Gross margin84.9%-1.3pp

Operating margin-47.1%-21.9pp

Net margin-76.8%-34.5pp

FCF margin-47.7%-22.1pp

Returns & leverage

See full

Return on equity-147.9%—

Debt / equity5.6×—

Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s financing cash flow?: Phathom Pharmaceuticals, Inc. (PHAT) reported financing cash flow of $66.64M in Q1 2026.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s financing cash flow?: Over 3 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s financing cash flow has grown at a -81.4% compound annual growth rate (CAGR), from $44.71M to -$288K.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.